Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-133-3 | CAS number: 764-99-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Oral: The acute oral LD50 was determined to be > 2000 mg/kg bw in rats.
Dermal: The acute dermal LD50 was determined to be > 2000 mg/kg bw in rabbits.
Inhal.: The LD50 in the inhalation risk test was determined to be > 9 mg/l.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2007-01-06 to 2007-01-16
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP and guideline study with minor deviations (details e.g. for housing conditions were not provided).
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- adopted December 17, 2001.
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Ace Animals, Boyertown, PA
- Age at study initiation: approx. 9 weeks
- Weight at study initiation: Body weight range in males was 238 - 274 grams and in females was 172 - 206 grams
- Fasting period before study: 16 - 20 h
- Housing:The animals were identified by cage notation and indelible body marks, and housed in suspended wire mesh cages; 1/cage. Bedding was placed beneath the cages and changed at least three times/week.
- Diet: Fresh PMI Rodent Chow (Diet #5021) was freely available
- Water: Ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): Temperature was controlled
- Photoperiod (hrs dark / hrs light): 12 hour light/dark cycle - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 0.55 mL
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5 male and 5 female rats
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were observed at 1, 2 and 4 hours postdose and once daily thereafter for 14 days for toxicity and pharmacological effects. All animals were observed twice daily for mortality. Body weights were recorded immediately pretest, weekly and at termination.
- Necropsy of survivors performed: All animals were examined for gross pathology. - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All ten animals survived the 2000 mg/kg oral dose
- Clinical signs:
- other: Instances of chromorhinorrhea, lethargy, ataxia, hunched posture, few feces, bloated abdomen, chromodacryorrhea, soiling of the anogenital area and/or emaciation ware noted in several rats during the study. Three rats were normal throughout the entire ob
- Gross pathology:
- The following abnormalities were noted in one or two rats at necropsy: slight or scattered red areas on the thymus, red areas on the intestines that ranged from slight or scattered to moderate or few; and/or slight or scattered soiling of the anogenital area. Bifurcated spleen was noted in two rats, although this abnormality should not be considered to be a result of treatment with the test article.
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: OECD GHS
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- GLP and guideline study
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Old study without GLP. Only basic details given.
- Species:
- rat
- Strain:
- other: Albino
- Sex:
- not specified
- Route of administration:
- inhalation: vapour
- Mortality:
- Exposure of rats for 4 h to an essentially saturated atmosphere generated at room temperature did not result in deaths.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2007-01-03 to 2007-01-17
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP and guideline study with minor deviations (Housing and feeding conditions)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- yes
- Remarks:
- Temperature of the animal room was outside of the protocol specific range
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1200 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Millbrook Breeding Labs, Amherst, MA
- Age at study initiation: 10 weeks
- Weight at study initiation: 330 - 388 grams for males and 206 - 221 grams for females
- Fasting period before study: no data
- Housing: Animals were housed 1 per cage in suspended wire cages. Bedding was placed beneath the cages and changed at least three times/week.
- Diet: Fresh PMI Rodent Chow (Diet #5012) was provided daily
- Water: Ad libitum
- Acclimation period: One week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17 -22 °C
- Humidity (%): 18 - 72 %
- Photoperiod: 12 hour light/dark - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: Dorsal area of the trunk
- coverage: 10 %
- Type of wrap if used: Impervious cuff and plastic-lined elastic bandage and secured with adhesive tape.
REMOVAL OF TEST SUBSTANCE
- Washing: Test sites were wiped with paper towels saturated with tap water and blotted dry with paper towels
- Time after start of exposure: 24 h
TEST MATERIAL
- Amount(s) applied: 0.41 to 0.44 cc for females, 0.66 to 0.78 cc for males
- Concentration: Undiluted
- Constant volume or concentration used: yes - Duration of exposure:
- 24 h
- Doses:
- 2000 mg/ kg bw
- No. of animals per sex per dose:
- 5 animals
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were observed 1,2 and 4 hours postdose and once daily for 14 days for toxicity and pharmacological effects. The animals were observed twice daily for mortality. Animals were observed daily for dermal observations. Body weights were recorded immediately pretest, weekly and at termination
- Necropsy of survivors performed: All animals were examined for gross pathology. The contents of the abdominal and thoracic cavities were examined in situ for gross pathology - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality. All animals survived the 2000 mg/kg bw dermal application.
- Clinical signs:
- other: Instances of chromorhinorrhea, chromodaeryorrhea and/or wetness of the anogenital area were observed in all animals during the study. These observations were most likely due to the fact that the animals wore Elizabethan-type collars and were therefore una
- Gross pathology:
- Necropsy results were normal in 4/10 animals. Six animals were noted with scattered flaking of the treated skin area.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- GLP and guideline study
Additional information
Oral:
For the investigation of the acute oral toxicity of the test item, five males and five females Wistar rats received a single oral dose of the test material at a dose level of 2000 mg/kg bw (GLP guideline study; MB Research Laboratories, 2007). All ten animals survived the 2000 mg/kg oral dose. Instances of chromorhinorrhea, lethargy, ataxia, hunched posture, few feces, bloated abdomen, chromodacryorrhea, soiling of the anogenital area and/or emaciation ware noted in several rats during the study. The following abnormalities were noted in one or two rats at necropsy: slight or scattered red areas on the thymus, red areas on the intestines that ranged from slight or scattered to moderate or few; and/or slight or scattered soiling of the anogenital area. Bifurcated spleen was noted in two rats, although this abnormality should not be considered to be a result of treatment with the test article. Under the conditions of this study, the LD50 of the test item after oral application was found to be greater than 2000 mg/kg bw.
This value is confirmed by two supporting studies with less reliability showing LD50 values of 3.73 mL/kg bw (Smyth, 1962) and 2.57 mL/kg bw (Bingman, 2001).
Dermal:
For the determination of the acute dermal toxicity, the test material was applied undiluted at a dose level of 2000 mg/kg bw to the clipped epidermis (dorsal parts of the trunk) of five male and five female rats and covered by a occlusive dressing for 24 hours. Systemic signs of toxicity were not noted. Necropsy results were normal in 4/10 animals. Six animals were noted with scattered flaking of the treated skin area. No mortality occurred. Under the conditions of this study, the LD50 of the test item after dermal application was found to be greater than 2000 mg/kg bw.
This value is confirmed by a supporting study with less reliability showing an LD50 value of 14.1 mL/kg bw (Smyth, 1962).
Inhalation:
In accordance with column 2 of REACH Annex VIII, the test acute toxicity after inhalation (required in section 8.5) does not need to be conducted as acute toxicity studies for oral and dermal application are available. In addition a supporting study with minor reliability shows, that the test substance is not acute toxic by inhalation as a saturated atmosphere generated at room temperature did not result in deaths of albino rats (Smyth, 1962).
Justification for classification or non-classification
Classification for acute toxicity is not warranted according to the criteria of EU Directive 67/548/EEC and EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
